FDAnews
www.fdanews.com/articles/139369-j-amp-j-tylenol-recall-spurred-by-high-levels-of-compound

J&J Tylenol Recall Spurred by High Levels of Compound

August 19, 2011
Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare is again recalling Tylenol products, this time for higher-than-expected levels of a compound.
Drug Industry Daily